Michael Tadao Inouye/LinkedIn, David Hunter/ariadnelabs.org
Sep 26, 2026, 15:42
Michael Tadao Inouye: The Next Frontier in Genomic Population Health
Michael Tadao Inouye, Director of Postgraduate Education (Research), Strand Lead – Molecular Informatics Resources and Tools at University of Cambridge, shared a post on LinkedIn about a recent article he and David J. Hunter co-authored, published in NEJM, adding:
“It’s been a long time coming but delighted to see that the NEJM Group review from David Hunter and me is out!
‘Clinical Uses of Common Genetic Variants Associated with Common Diseases.’
The next 10 years will be a very exciting time for genomic population health.”
Title: Clinical Uses of Common Genetic Variants Associated with Common Diseases
Authors: David J. Hunter, Michael Inouye
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience